Settivari Raja S, Ball Nicholas, Murphy Lynea, Rasoulpour Reza, Boverhof Darrell R, Carney Edward W
Toxicology and Environmental Research and Consulting, The Dow Chemical Company, Midland, Michigan, USA.
J Am Assoc Lab Anim Sci. 2015 Mar;54(2):214-23.
Interest in applying 21st-century toxicity testing tools for safety assessment of industrial chemicals is growing. Whereas conventional toxicology uses mainly animal-based, descriptive methods, a paradigm shift is emerging in which computational approaches, systems biology, high-throughput in vitro toxicity assays, and high-throughput exposure assessments are beginning to be applied to mechanism-based risk assessments in a time- and resource-efficient fashion. Here we describe recent advances in predictive safety assessment, with a focus on their strategic application to meet the changing demands of the chemical industry and its stakeholders. The opportunities to apply these new approaches is extensive and include screening of new chemicals, informing the design of safer and more sustainable chemical alternatives, filling information gaps on data-poor chemicals already in commerce, strengthening read-across methodology for categories of chemicals sharing similar modes of action, and optimizing the design of reduced-risk product formulations. Finally, we discuss how these predictive approaches dovetail with in vivo integrated testing strategies within repeated-dose regulatory toxicity studies, which are in line with 3Rs principles to refine, reduce, and replace animal testing. Strategic application of these tools is the foundation for informed and efficient safety assessment testing strategies that can be applied at all stages of the product-development process.
将21世纪毒性测试工具应用于工业化学品安全评估的兴趣正在不断增长。传统毒理学主要使用基于动物的描述性方法,而现在正出现一种范式转变,即计算方法、系统生物学、高通量体外毒性测定和高通量暴露评估开始以高效利用时间和资源的方式应用于基于机制的风险评估。在此,我们描述了预测性安全评估的最新进展,重点关注其战略应用,以满足化学工业及其利益相关者不断变化的需求。应用这些新方法的机会广泛,包括筛选新化学品、为更安全和更可持续的化学替代品设计提供信息、填补已上市数据匮乏化学品的信息空白、加强对具有相似作用模式的化学品类别进行跨类别类推的方法,以及优化低风险产品配方的设计。最后,我们讨论这些预测方法如何与重复剂量监管毒性研究中的体内综合测试策略相契合,这些策略符合3R原则,即优化、减少和替代动物试验。这些工具的战略应用是在产品开发过程的所有阶段都可应用的明智且高效的安全评估测试策略的基础。